Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viridian Therapeutics, Inc.\DE (VRDN) Accumulated Expenses: 2014-2024

Historic Accumulated Expenses for Viridian Therapeutics, Inc.\DE (VRDN) over the last 11 years, with Dec 2024 value amounting to $45.7 million.

  • Viridian Therapeutics, Inc.\DE's Accumulated Expenses rose 16.97% to $40.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.6 million, marking a year-over-year increase of 16.97%. This contributed to the annual value of $45.7 million for FY2024, which is 89.69% up from last year.
  • Viridian Therapeutics, Inc.\DE's Accumulated Expenses amounted to $45.7 million in FY2024, which was up 89.69% from $24.1 million recorded in FY2023.
  • Viridian Therapeutics, Inc.\DE's 5-year Accumulated Expenses high stood at $45.7 million for FY2024, and its period low was $9.7 million during FY2020.
  • Over the past 3 years, Viridian Therapeutics, Inc.\DE's median Accumulated Expenses value was $24.1 million (recorded in 2023), while the average stood at $29.6 million.
  • Data for Viridian Therapeutics, Inc.\DE's Accumulated Expenses shows a peak YoY skyrocketed of 89.96% (in 2020) over the last 5 years.
  • Over the past 5 years, Viridian Therapeutics, Inc.\DE's Accumulated Expenses (Yearly) stood at $9.7 million in 2020, then climbed by 13.55% to $11.0 million in 2021, then surged by 70.87% to $18.8 million in 2022, then rose by 28.05% to $24.1 million in 2023, then spiked by 89.69% to $45.7 million in 2024.